News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
About Mesothelioma
Latest News
- Wake Forest School of Medicine and FirstHealth of ...
- Mesothelioma Patients Eligible for Air Transportat...
- Mesothelioma Awareness Day Proposed as National Ev...
- Tougher Toxic Chemical Legislation Being Considere...
- Texas Cancer Center Offers Hope to Mesothelioma Pa...
- Alimta Extends Life of Lung Cancer Patients
- Iron Range Mesothelioma Health Screenings Underway...
- Mesothelioma Specialists Offer Optimal Care
- Chaplains Offer Comfort to Patients
- Mesothelioma Awareness Day - September 26
News Archives
- April 2007
- May 2007
- June 2007
- July 2007
- August 2007
- September 2007
- October 2007
- November 2007
- December 2007
- January 2008
- February 2008
- March 2008
- April 2008
- May 2008
- June 2008
- July 2008
- August 2008
- September 2008
- October 2008
- November 2008
- December 2008
- January 2009
- February 2009
- March 2009
- April 2009
- May 2009
- June 2009
- July 2009
- August 2009
- September 2009
- October 2009
- November 2009
Tuesday, October 13, 2009
Study: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for MesotheliomaStart Date: January 2009
End Date: January 2020
Recruiting Contacts
Andrea Foster, 416-946-4501 ext 5010, Andrea.Foster@Uhn.on.ca
Jennifer Hornby, BSc CCRP 416-340-4857, Jennifer.Hornby@uhn.on.ca
Information
The University Health Network of Toronto is currently recruiting participants for a clinical trial using a combination of Pemetrexed (Alimta) with Cisplatin prior to surgery followed by radiation therapy after surgery. The goal enrollment for the trial is 45 patients that have been diagnosed with malignant pleural mesothelioma but have not yet undergone treatment.
Previous studies have shown that complete removal of mesothelioma is possible in approximately 30% of the patients, with treatment typically continuing with chemotherapy followed by radiation. The chances of the tumor returning after this trimodal therapy remains high, and the chances of long term survival remains low.
According to the trial information, the combination of Pemetrexed (Alimta) with Cisplatin as chemotherapy treatment is likely to benefit, and potentially cure, a group of patients.
For complete information see ClinicalTrials.
Labels: ClinicalTrial, mesothelioma
posted by Nancy Meredith at 1:07 PM
